Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule


2003 2004 2005 2006 2007 2008 2009 2010 2011 2012


Ahmed H, Banerjee PP, Vasta GR. Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation. Biochem Biophys Res Commun 2007; 358(1):241-246.

Avvisato CL, Yang X, Shah S, Hoxter B, Li W, Gaynor R, Pestell R, Tozeren A, Byers SW. Mechanical force modulates global gene expression and beta-catenin signaling in colon cancer cells. J Cell Sci 2007; 120(Pt 15):2672-2682.

Bharti, S., Inoue, H., Bharti, K., Hirsch, D. S., Nie, Z., Yoon, H. Y., Artym, V., Yamada, K. M., Mueller, S. C., Barr, V. A., and Randazzo, P. A. Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol, 27: 8271-8283, 2007.

Bouker, K. B., Skaar, T. C., Harburger, D. S., Riggins, R. B., Fernandez, D. R., Zwart, A., and Clarke, R. The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines. Cancer Genet Cytogenet, 175: 61-64, 2007.

Casimiro, M., Rodriguez, O., Pootrakul, L., Aventian, M., Lushina, N., Cromelin, C., Ferzli, G., Johnson, K., Fricke, S., Diba, F., Kallakury, B., Ohanyerenwa, C., Chen, M., Ostrowski, M., Hung, M. C., Rabbani, S. A., Datar, R., Cote, R., Pestell, R., and Albanese, C. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Cancer Res, 67: 4364-4372, 2007.

Eliseeva ED, Valkov V, Jung M, Jung MO. 2007. Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 6(9):2391-2398.

Fan, S., Meng, Q., Laterra, J. J., and Rosen, E. M. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene, 26: 4774-4796, 2007.

Gedil, M.A., N.K. Steiner, and C.K. Hurley. 2007. KIR3DL2: Diversity in a hematopoietic stem cell transplant population. Tissue Antigens 70:228-32.

Gomez, B. P., Riggins, R. B., Shajahan, A. N., Klimach, U., Wang, A., Crawford, A. C., Zhu, Y., Zwart, A., Wang, M., and Clarke, R. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J, 21: 4013-4027, 2007.

Hou, L., N. Steiner, M. Chen, I. Belle, J. Ng and C.K. Hurley. 2007. KIR2DL1 allelic diversity: Four new alleles characterized in a bone marrow transplant population and three families. Tissue Antigens 69:250-254.

Hou, L., M. Chen, N.K. Steiner, I. Belle, C. Turino, J. Ng, and C.K. Hurley. 2007. Seventeen novel alleles add to the already extensive KIR3DL3 diversity. Tissue Antigens 70:449-454.

Jiang S, Li P, Lee SL, Lin CY, Long YQ, Johnson MD, Dickson RB, Roller PP. 2007. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase. Org Lett 9(1):9-12.

Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z. 2007. Corrigenda: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13(9):1120.

Lahusen, T., Fereshteh, M., Oh, A., Wellstein, A., and Riegel, A. T. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res, 67: 7256-7265, 2007.

Lee C, Kim JS, Waldman T. Activated PI3K signaling as an endogenous inducer of p53 in human cancer. Cell Cycle 2007; 6(4):394-396.

Lee MS, Tseng IC, Wang Y, Kiyomiya K, Johnson MD, Dickson RB, Lin CY. 2007. Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Am J Physiol Cell Physiol 293(1):C95-105.

Lee SA, Jung M. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. J Biol Chem 2007; 282(20):15271-15283.

Ma, Y., Hu, C., Riegel, A. T., Fan, S., and Rosen, E. M. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity. Mol Endocrinol, 21: 1905-1923, 2007.

Martin, M. B., Reiter, R., Johnson, M., Shah, M. S., Iann, M. C., Singh, B., Richards, J. K., Wang, A., and Stoica, A. Effects of tobacco smoke condensate on estrogen receptor-alpha gene expression and activity. Endocrinology, 148: 4676-4686, 2007.

Nam DH, Ramachandran S, Song DK, Kwon KY, Jeon DS, Shin SJ, Kwon SH, Cha SD, Bae I, Cho CH. 2007. Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone. Mol Hum Reprod 13(11):829-836.

Naughton C, MacLeod K, Kuske B, Clarke R, Cameron DA, Langdon SP. 2007. Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistance. Mol Endocrinol; 21(11):2615-2626.

Quann EJ, Khwaja F, Zavitz KH, Djakiew D. The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res 2007; 67(7):3254-3262.

Rae, J., Creighton, C., Meck, J., Haddad, B., and Johnson, M. MDA-MB-435 cells are derived from M14 melanoma cells: a loss for breast cancer but a boon for melanoma research. Breast Can Res Treat, 104: 13-19, 2007.

Riggins, R. B., Schrecengost, R. S., Guerrero, M. S., and Bouton, A. H. Pathways to tamoxifen resistance. Cancer Lett, 256: 1-24, 2007.

Samara RN, Laguinge LM, Jessup JM. Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. Cancer Res 2007; 67(10):4774-4782.

Schrecengost RS, Riggins RB, Thomas KS, Guerrero MS, Bouton AH. 2007. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res 67(13):6174-6182.

Shulse, C., N. K. Steiner, C. K. Hurley. 2007. Allelic diversity in KIR2DL4 in a bone marrow transplant population: description of three novel alleles. Tissue Antigens 70:157-9.

Villar J, Arenas MI, MacCarthy CM, Blanquez MJ, Tirado OM, Notario V. 2007. PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Res 67(22):10859-10868.